نتایج جستجو برای: sof

تعداد نتایج: 743  

2016
Pegah Golabi Elzafir Elsheikh Azza Karrar James M. Estep Issah Younossi Maria Stepanova Lynn Gerber Zobair M. Younossi

Mental and emotional health (MEH) impairment is commonly encountered in hepatitis C patients. Although the exact mechanism remains unknown, alterations in neurotransmitter and cytokine levels maybe associated with hepatitis C virus (HCV)-related MEH issues.The aim of the study was to assess association of serum biomarkers with self-reports of MEH in HCV patients before treatment and after achie...

2016
Vincent Leroy Peter Angus Jean‐Pierre Bronowicki Gregory J. Dore Christophe Hezode Stephen Pianko Stanislas Pol Katherine Stuart Edmund Tse Fiona McPhee Rafia Bhore Maria Jesus Jimenez‐Exposito Alexander J. Thompson

UNLABELLED Patients with hepatitis C virus (HCV) genotype 3 infection, especially those with advanced liver disease, are a challenging population in urgent need of optimally effective therapies. The combination of daclatasvir (DCV; pangenotypic nonstructural protein 5A inhibitor) and sofosbuvir (SOF; nucleotide nonstructural protein 5B inhibitor) for 12 weeks previously showed high efficacy (96...

2013
Julien Glicenstein

This year, we are pleased to celebrate the 60 years of the French Society of Reconstructive and Aesthetic Plastic Surgery at its national convention in La Défense. but this is not the only anniversary that Laboratoires SebbIN celebrates this year! Indeed, there are just 10 years, Sebbin put up a meticulous clinical follow-up of almost 250 patients carriers of our breast implants. The first stud...

2015
Eric G. Meissner Jérémie Decalf Armanda Casrouge Henry Masur Shyam Kottilil Matthew L. Albert Darragh Duffy Stephen J Polyak

Serum levels of the interferon (IFN)-stimulated chemokine CXCL10 are increased during chronic HCV infection and associate with outcome of IFN-based therapy. Elevated levels of NH2-terminal truncated CXCL10 (3-77aa), produced by DPP4 cleavage, negatively associate with spontaneous clearance of acute HCV infection and sustained virological response (SVR) with IFN-based therapy for chronic infecti...

2018
John Eppensteiner Robert Patrick Davis Andrew S. Barbas Jean Kwun Jaewoo Lee

Despite significant improvements in injury prevention and emergency response, injury-related death and morbidity continues to increase in the US and worldwide. Patients with trauma, invasive operations, anti-cancer treatment, and organ transplantation produce a host of danger signals and high levels of pro-inflammatory and pro-thrombotic mediators, such as damage-associated molecular patterns (...

2016
Brittany E Yee Nghia H Nguyen Minjuan Jin Glen Lutchman Joseph K Lim Mindie H Nguyen

BACKGROUND High sustained virological response at 12 weeks after end of treatment (SVR12) with 12 weeks of simeprevir and sofosbuvir±ribavirin (SMV+SOF±RBV) has been demonstrated in hepatitis C virus genotype 1 (HCV-1) but is based on limited data. Therefore, we performed a meta-analysis of available data evaluating the effectiveness of SMV+SOF±RBV in HCV-1. METHODS We performed a comprehensi...

2017
Jona T. Stahmeyer Siegbert Rossol Sebastian Liersch Ines Guerra Christian Krauth

BACKGROUND Infections with the hepatitis C virus (HCV) are a global public health problem. Long-term consequences are the development of liver cirrhosis and hepatocellular carcinoma. Newly introduced direct acting antivirals, especially interferon-free regimens, have improved rates of sustained viral response above 90% in most patient groups and allow treating patients who were ineligible for t...

Journal: :Medicine 2016
Zobair M Younossi Maria Stepanova Henry L Y Chan Mei H Lee Ming-Lung Yu Yock Y Dan Moon S Choi Linda Henry

Prevalence of chronic hepatitis C (CH-C) infection in patients of Asian ancestry ranges between 1% and 20%. Interferon (IFN)- and ribavirin (RBV)-containing regimens for CH-C have a negative impact on patient-reported outcomes (PROs) during treatment. The aim of this study was to assess the impact of IFN-free RBV-free sofosbuvir (SOF)-based regimens on PROs in CH-C patients of Asian ancestry. I...

Journal: :Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2016
Jérôme Dumortier Vincent Leroy Christophe Duvoux Victor de Ledinghen Claire Francoz Pauline Houssel-Debry Sylvie Radenne Louis d'Alteroche Claire Fougerou-Leurent Valérie Canva Vincent di Martino Filomena Conti Nassim Kamar Christophe Moreno Pascal Lebray Albert Tran Camille Besch Alpha Diallo Alexandra Rohel Emilie Rossignol Armand Abergel Danielle Botta-Fridlund Audrey Coilly Didier Samuel Jean-Charles Duclos-Vallée Georges-Philippe Pageaux

Recurrence of hepatitis C virus (HCV) after liver transplantation (LT) can rapidly lead to liver graft cirrhosis and, therefore, graft failure and retransplantation or death. The aim of the present study was to assess efficacy and tolerance of sofosbuvir (SOF)-based regimens for the treatment of HCV recurrence in patients with severe fibrosis after LT. The Compassionate Use of Protease Inhibito...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید